The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... plans and options to determine the best way to incorporate Spravato into their care ...

But there are specific kinds that are best: “Cough medicines that contain guaifenesin and dextromethorphan should be okay for a short time,” says Meleen Chuang, MD, the chief of obstetrics and ...

Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

As a nurse, I’ve seen how the virus can cause serious health complications. Check out the following items to keep on hand to ...

President Trump’s nominee to head the Department of Health and Human Services, Robert Kennedy Jr., will soon go before the ...